Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:37:44 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



News for U:STIM from 2023-05-09 to 2024-05-08 - 40 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-07 07:30U:STIMNews ReleaseNeuronetics Reports Record First Quarter 2024 Financial and Operating Results
2024-05-03 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-05-01 08:31U:STIMNews ReleaseNeuroStar(TM) TMS Advances Treatment for Adolescents During Mental Health Awareness Month
2024-04-23 16:30U:STIMNews ReleaseNeuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
2024-04-10 08:31U:STIMNews ReleaseNew Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
2024-03-27 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-03-25 08:30U:STIMNews ReleaseNeuroStar(TM) Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
2024-03-07 08:22U:STIMNews ReleaseNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
2024-03-05 07:30U:STIMNews ReleaseNeuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
2024-02-20 08:30U:STIMNews ReleaseNeuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
2024-02-12 08:32U:STIMNews ReleaseNeuronetics Launches Latest Evolution in its TrakStar ‚ ® Patient Data Management System
2024-02-06 08:28U:STIMNews ReleaseNeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
2024-01-08 08:30U:STIMNews ReleaseNeuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
2023-12-18 08:49U:STIMNews ReleaseNeuronetics Receives 510(k) Clearance for NeuroSite ¢ „ ¢ ‚  Coil Placement Accessory
2023-12-04 08:56U:STIMNews ReleaseNeuroStar TMS Receives Expanded Regulatory Approval in Japan
2023-11-15 16:15U:STIMNews ReleaseNeuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
2023-11-13 08:57U:STIMNews ReleaseNeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
2023-11-09 08:32U:STIMNews ReleaseNeuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
2023-11-07 07:30U:STIMNews ReleaseNeuronetics Reports Third Quarter 2023 Financial and Operating Results
2023-11-06 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-10-24 08:30U:STIMNews ReleaseNeuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
2023-10-16 08:56U:STIMNews ReleaseBrain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
2023-10-03 09:21U:STIMNews ReleaseNeuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
2023-09-12 08:56U:STIMNews ReleaseIn Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
2023-08-21 08:56U:STIMNews ReleaseNeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
2023-08-14 09:02U:STIMNews ReleaseNeuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar ‚ ® Platform
2023-08-08 07:30U:STIMNews ReleaseNeuronetics Reports Record Second Quarter 2023 Financial and Operating Results
2023-08-04 16:30U:STIMNews ReleaseNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-07-25 08:30U:STIMNews ReleaseNeuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
2023-07-19 08:56U:STIMNews ReleaseNeuronetics Announces Expanded TMS Therapy Access Through Aetna ‚ ® Health Plans
2023-07-17 08:46U:STIMNews ReleaseNeuroStar Achieves Milestone Regulatory Clearance in South Korea
2023-07-11 08:56U:STIMNews ReleaseNeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
2023-06-12 08:59U:STIMNews ReleaseNeuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
2023-05-30 13:51U:STIMNews ReleaseNeuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression
2023-05-26 08:59U:STIMNews ReleaseNeuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
2023-05-24 16:30U:STIMNews ReleaseNeuronetics to Present at the William Blair 43rd Annual Growth Stock Conference
2023-05-23 08:46U:STIMNews ReleaseNew Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
2023-05-15 08:56U:STIMNews ReleaseNeuronetics Wins 2023 Bell Seal for Workplace Mental Health
2023-05-09 17:01U:STIMNews ReleaseNeuronetics to Present at the JMP Securities Life Sciences Conference
2023-05-09 07:30U:STIMNews ReleaseNeuronetics Reports Record First Quarter 2023 Financial and Operating Results